ALPHANATE FOR INJECTION 250 iu/vial
Product details
Registration number: SIN09031P
Classification: Prescription Only
Active ingredients:
- FACTOR VIII
- VON WILLEBRAND FACTOR
Strength:
- 250 iu/vial
- >400 iu / 1000 iu Factor VIII
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: GRIFOLS ASIA PACIFIC PTE. LTD.
ATC code: B02BD06
HSA approval date: 28 November 1996
Manufacturer(s):
- GRIFOLS BIOLOGICALS LLC.
- INSTITUTO GRIFOLS, S.A. (manufacturer for WFI)
- ROVI PHARMA INDUSTRIAL SERVICES, S.A. (alternate manufacturer for WFI)
- Grifols Therapeutics LLC (Alternate Manufacturer for Cryoprecipitate)
Manufacturing country/countries: UNITED STATES; SPAIN
What are the HSA registration number and classification for ALPHANATE FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN09031P
Classification: Prescription Only
What active ingredients and strength are recorded for ALPHANATE FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- FACTOR VIII
- VON WILLEBRAND FACTOR
Strength:
- 250 iu/vial
- >400 iu / 1000 iu Factor VIII
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ALPHANATE FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for ALPHANATE FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: GRIFOLS ASIA PACIFIC PTE. LTD.
Which manufacturers and countries are listed for ALPHANATE FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GRIFOLS BIOLOGICALS LLC.
- INSTITUTO GRIFOLS, S.A. (manufacturer for WFI)
- ROVI PHARMA INDUSTRIAL SERVICES, S.A. (alternate manufacturer for WFI)
- Grifols Therapeutics LLC (Alternate Manufacturer for Cryoprecipitate)
Manufacturing country/countries: UNITED STATES; SPAIN
Where can I look up ALPHANATE FOR INJECTION 250 iu/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN09031P or the exact product name ALPHANATE FOR INJECTION 250 iu/vial. The general register link does not preselect this product.
What are the source dates for this ALPHANATE FOR INJECTION 250 iu/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ALPHANATE FOR INJECTION 250 iu/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN09031P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)